Sisällysluettelo:
“…Progress and trends in
complement therapeutics -- Inhibition of the serine proteases of the
complement system -- Role of MASP-1/3 in
complement activation -- Membrane-bound
complement regulatory proteins as biomarkers and potential therapeutic targets for SLE -- DAF as a therapeutic target for steroid hormones: implications for host-pathogen interactions -- Targeting gC1qR domains for therapy against infection and inflammation -- Alternative C5a receptor function -- Effects of selective
complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upreglation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood -- CR2-mediated targeting of
complement inhibitors: bench-to-bedside using a novel strategy for site-specific
complement modulation -- Paroxysmal nocturnal hemoglobinuria and the
complement system: recent insights and novel anticomplement strategies -- Defective
complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches -- C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families --
Complement-targeted therapeutics in periodontitis --
Complement system activation in cardiac and skeletal muscle pathology: friend or foe? …”
Tallennettuna: